Find Resources and Information enter key words 1,576 results Items per page: 20 50 500 Filtered By: Clear All Your search did not return any results. Please try another search. Blog Posts An Artist and Advocate Returns to the ZERO Summit for a Second Year Brandon Wilhelmsen Utah artist Brandon Wilhelmsen shares his inspiring story of using his talents to raise prostate cancer awareness after his father's diagnosis, donating artwork for ZERO's events. He discusses returning to ZERO's Virtual Summit to advocate for patients and families." Prostate Cancer News The Potential Role for PARP Inhibitors in Prostate Cancer Precision oncology involves matching molecular aspects of a tumor to drugs targeting those pathways and is a routine consideration for patients with l... Prostate Cancer News FDA Approves Zytiga for High-Risk Prostate Cancer Janssen Biotech announced that the Food and Drug Administration has approved Zytiga (abiraterone acetate) in combination with prednisone for high-risk... Prostate Cancer News Study Findings Complicate the Paradigm for Hormone-Sensitive Prostate Cancer Clinical trial results that challenge the standard of care sometimes make it more difficult for physicians to decide how to treat their patients. Such... Webpage Prostate Cancer Stages and Treatment Prostate cancer is treatable, especially if caught early. There are many treatments to consider—knowing the stage is vital to understanding your options. Prostate Cancer News Testosterone Replacement Linked to Lower Rates of Aggressive Prostate Cancer Men who receive testosterone replacement therapy (TRT) had an increased rate of favorable-risk prostate cancer compared to those who did not use the t... Prostate Cancer News Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer Results from a prospective clinical trial suggest a single, 19-Gray (Gy) high-dose–rate (HDR) of brachytherapy is a safe and effective option over lon... Prostate Cancer News Cruisin’ for a Cure Showcases Cars and Prostate Cancer Research A display of thousands of cars at the OC Fair and Event Center helped rev up support for prostate cancer research last Saturday. The 18th annual Cruis... Prostate Cancer News Low-PSA, High-Grade Prostate Cancer Especially Lethal Patients with Gleason 8 to 10 prostate cancer (PCa) and PSA values of 2.5 ng/mL or less may harbor hormone-resistant disease that is more lethal than... Prostate Cancer News VERU-944 Therapy for Hot Flashes in Men Receiving Prostate Cancer Hormone Treatment Heads to Trial Veru Healthcare is set to begin a Phase 2 clinical trial evaluating VERU-944 (APP-944) for the treatment of hot flashes in men receiving hormone thera... Prostate Cancer News Arnold Palmer’s Lasting Legacy: Prostate Cancer Prevention And Treatment, Medical Tips For You A less well-known part of Arnold Palmer’s history was his role in promoting prostate cancer control. At age 67 in 1997, Arnold had a PSA screening tes... Prostate Cancer News Prostate Cancer Patients Can Improve Bone Health With Osteoporosis Medications Men with non-metastatic prostate cancer who receive androgen deprivation therapy (ADT) risk loss of bone mineral density (BMD) and fractures, but both... Prostate Cancer News Prostate Cancer in Blacks and Hispanics More Aggressive and Poorly Treated in US, Study Says African-American and Hispanic prostate cancer patients are at higher risk of aggressive disease — but less likely to be treated for their cancer — tha... Prostate Cancer News Trial of Miltuximab in Prostate, Other Cancers Gets Nod to Enroll Additional Patients The first-in-human clinical trial assessing the safety and tolerability of Miltuximab (MIL-38) — a radiolabeled antibody designed to image prostate, b... Prostate Cancer News Prostate Cancer Risk Lower in Men With Prostate Atrophy Prostate atrophy (PA) is commonly found in prostate biopsy specimens, but its clinical relevance is unknown. Now researchers have discovered a dose-de... Prostate Cancer News Robotic Surgery Is Milestone Advancement for Prostate Cancer Treatment Robotic surgery has had a significant impact on patients with prostate cancer undergoing a prostatectomy. Compared with open surgery, “the recovery... Prostate Cancer News PET Identifies Which Prostate Cancer Patients Can Benefit from Salvage Radiation Treatment For prostate cancer patients who have rising levels of PSA (a cancer indicator) even after radical prostatectomy, early treatment makes a difference.... Prostate Cancer News Explaining Androgen Receptor-indifferent Prostate Cancer The evidence base for the existence of androgen receptor (AR)-“indifferent” cell states in some prostate tumors is growing stronger, according to Ana... Prostate Cancer News Hope for Metastatic Prostate Cancer Patients: Targeted Alpha Therapy Shows Impressive Results Nearly three years of research have brought about remarkable results for the majority of 80 patients subjected to targeted alpha therapy of metastatic... Prostate Cancer News FDA Grants Janssen Biotech’s Apalutamide Priority Review Designation to Treat Non-Metastatic CRPC The U.S. Food and Drug Administration (FDA) has granted priority review status to apalutamide — an investigational androgen receptor inhibitor — to tr... Previous Page Page 1 ...Page 6 Page 7 Page 8 ...Page 79 Next Page
enter key words 1,576 results Items per page: 20 50 500 Filtered By: Clear All Your search did not return any results. Please try another search. Blog Posts An Artist and Advocate Returns to the ZERO Summit for a Second Year Brandon Wilhelmsen Utah artist Brandon Wilhelmsen shares his inspiring story of using his talents to raise prostate cancer awareness after his father's diagnosis, donating artwork for ZERO's events. He discusses returning to ZERO's Virtual Summit to advocate for patients and families." Prostate Cancer News The Potential Role for PARP Inhibitors in Prostate Cancer Precision oncology involves matching molecular aspects of a tumor to drugs targeting those pathways and is a routine consideration for patients with l... Prostate Cancer News FDA Approves Zytiga for High-Risk Prostate Cancer Janssen Biotech announced that the Food and Drug Administration has approved Zytiga (abiraterone acetate) in combination with prednisone for high-risk... Prostate Cancer News Study Findings Complicate the Paradigm for Hormone-Sensitive Prostate Cancer Clinical trial results that challenge the standard of care sometimes make it more difficult for physicians to decide how to treat their patients. Such... Webpage Prostate Cancer Stages and Treatment Prostate cancer is treatable, especially if caught early. There are many treatments to consider—knowing the stage is vital to understanding your options. Prostate Cancer News Testosterone Replacement Linked to Lower Rates of Aggressive Prostate Cancer Men who receive testosterone replacement therapy (TRT) had an increased rate of favorable-risk prostate cancer compared to those who did not use the t... Prostate Cancer News Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer Results from a prospective clinical trial suggest a single, 19-Gray (Gy) high-dose–rate (HDR) of brachytherapy is a safe and effective option over lon... Prostate Cancer News Cruisin’ for a Cure Showcases Cars and Prostate Cancer Research A display of thousands of cars at the OC Fair and Event Center helped rev up support for prostate cancer research last Saturday. The 18th annual Cruis... Prostate Cancer News Low-PSA, High-Grade Prostate Cancer Especially Lethal Patients with Gleason 8 to 10 prostate cancer (PCa) and PSA values of 2.5 ng/mL or less may harbor hormone-resistant disease that is more lethal than... Prostate Cancer News VERU-944 Therapy for Hot Flashes in Men Receiving Prostate Cancer Hormone Treatment Heads to Trial Veru Healthcare is set to begin a Phase 2 clinical trial evaluating VERU-944 (APP-944) for the treatment of hot flashes in men receiving hormone thera... Prostate Cancer News Arnold Palmer’s Lasting Legacy: Prostate Cancer Prevention And Treatment, Medical Tips For You A less well-known part of Arnold Palmer’s history was his role in promoting prostate cancer control. At age 67 in 1997, Arnold had a PSA screening tes... Prostate Cancer News Prostate Cancer Patients Can Improve Bone Health With Osteoporosis Medications Men with non-metastatic prostate cancer who receive androgen deprivation therapy (ADT) risk loss of bone mineral density (BMD) and fractures, but both... Prostate Cancer News Prostate Cancer in Blacks and Hispanics More Aggressive and Poorly Treated in US, Study Says African-American and Hispanic prostate cancer patients are at higher risk of aggressive disease — but less likely to be treated for their cancer — tha... Prostate Cancer News Trial of Miltuximab in Prostate, Other Cancers Gets Nod to Enroll Additional Patients The first-in-human clinical trial assessing the safety and tolerability of Miltuximab (MIL-38) — a radiolabeled antibody designed to image prostate, b... Prostate Cancer News Prostate Cancer Risk Lower in Men With Prostate Atrophy Prostate atrophy (PA) is commonly found in prostate biopsy specimens, but its clinical relevance is unknown. Now researchers have discovered a dose-de... Prostate Cancer News Robotic Surgery Is Milestone Advancement for Prostate Cancer Treatment Robotic surgery has had a significant impact on patients with prostate cancer undergoing a prostatectomy. Compared with open surgery, “the recovery... Prostate Cancer News PET Identifies Which Prostate Cancer Patients Can Benefit from Salvage Radiation Treatment For prostate cancer patients who have rising levels of PSA (a cancer indicator) even after radical prostatectomy, early treatment makes a difference.... Prostate Cancer News Explaining Androgen Receptor-indifferent Prostate Cancer The evidence base for the existence of androgen receptor (AR)-“indifferent” cell states in some prostate tumors is growing stronger, according to Ana... Prostate Cancer News Hope for Metastatic Prostate Cancer Patients: Targeted Alpha Therapy Shows Impressive Results Nearly three years of research have brought about remarkable results for the majority of 80 patients subjected to targeted alpha therapy of metastatic... Prostate Cancer News FDA Grants Janssen Biotech’s Apalutamide Priority Review Designation to Treat Non-Metastatic CRPC The U.S. Food and Drug Administration (FDA) has granted priority review status to apalutamide — an investigational androgen receptor inhibitor — to tr... Previous Page Page 1 ...Page 6 Page 7 Page 8 ...Page 79 Next Page
Blog Posts An Artist and Advocate Returns to the ZERO Summit for a Second Year Brandon Wilhelmsen Utah artist Brandon Wilhelmsen shares his inspiring story of using his talents to raise prostate cancer awareness after his father's diagnosis, donating artwork for ZERO's events. He discusses returning to ZERO's Virtual Summit to advocate for patients and families."
Prostate Cancer News The Potential Role for PARP Inhibitors in Prostate Cancer Precision oncology involves matching molecular aspects of a tumor to drugs targeting those pathways and is a routine consideration for patients with l...
Prostate Cancer News FDA Approves Zytiga for High-Risk Prostate Cancer Janssen Biotech announced that the Food and Drug Administration has approved Zytiga (abiraterone acetate) in combination with prednisone for high-risk...
Prostate Cancer News Study Findings Complicate the Paradigm for Hormone-Sensitive Prostate Cancer Clinical trial results that challenge the standard of care sometimes make it more difficult for physicians to decide how to treat their patients. Such...
Webpage Prostate Cancer Stages and Treatment Prostate cancer is treatable, especially if caught early. There are many treatments to consider—knowing the stage is vital to understanding your options.
Prostate Cancer News Testosterone Replacement Linked to Lower Rates of Aggressive Prostate Cancer Men who receive testosterone replacement therapy (TRT) had an increased rate of favorable-risk prostate cancer compared to those who did not use the t...
Prostate Cancer News Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer Results from a prospective clinical trial suggest a single, 19-Gray (Gy) high-dose–rate (HDR) of brachytherapy is a safe and effective option over lon...
Prostate Cancer News Cruisin’ for a Cure Showcases Cars and Prostate Cancer Research A display of thousands of cars at the OC Fair and Event Center helped rev up support for prostate cancer research last Saturday. The 18th annual Cruis...
Prostate Cancer News Low-PSA, High-Grade Prostate Cancer Especially Lethal Patients with Gleason 8 to 10 prostate cancer (PCa) and PSA values of 2.5 ng/mL or less may harbor hormone-resistant disease that is more lethal than...
Prostate Cancer News VERU-944 Therapy for Hot Flashes in Men Receiving Prostate Cancer Hormone Treatment Heads to Trial Veru Healthcare is set to begin a Phase 2 clinical trial evaluating VERU-944 (APP-944) for the treatment of hot flashes in men receiving hormone thera...
Prostate Cancer News Arnold Palmer’s Lasting Legacy: Prostate Cancer Prevention And Treatment, Medical Tips For You A less well-known part of Arnold Palmer’s history was his role in promoting prostate cancer control. At age 67 in 1997, Arnold had a PSA screening tes...
Prostate Cancer News Prostate Cancer Patients Can Improve Bone Health With Osteoporosis Medications Men with non-metastatic prostate cancer who receive androgen deprivation therapy (ADT) risk loss of bone mineral density (BMD) and fractures, but both...
Prostate Cancer News Prostate Cancer in Blacks and Hispanics More Aggressive and Poorly Treated in US, Study Says African-American and Hispanic prostate cancer patients are at higher risk of aggressive disease — but less likely to be treated for their cancer — tha...
Prostate Cancer News Trial of Miltuximab in Prostate, Other Cancers Gets Nod to Enroll Additional Patients The first-in-human clinical trial assessing the safety and tolerability of Miltuximab (MIL-38) — a radiolabeled antibody designed to image prostate, b...
Prostate Cancer News Prostate Cancer Risk Lower in Men With Prostate Atrophy Prostate atrophy (PA) is commonly found in prostate biopsy specimens, but its clinical relevance is unknown. Now researchers have discovered a dose-de...
Prostate Cancer News Robotic Surgery Is Milestone Advancement for Prostate Cancer Treatment Robotic surgery has had a significant impact on patients with prostate cancer undergoing a prostatectomy. Compared with open surgery, “the recovery...
Prostate Cancer News PET Identifies Which Prostate Cancer Patients Can Benefit from Salvage Radiation Treatment For prostate cancer patients who have rising levels of PSA (a cancer indicator) even after radical prostatectomy, early treatment makes a difference....
Prostate Cancer News Explaining Androgen Receptor-indifferent Prostate Cancer The evidence base for the existence of androgen receptor (AR)-“indifferent” cell states in some prostate tumors is growing stronger, according to Ana...
Prostate Cancer News Hope for Metastatic Prostate Cancer Patients: Targeted Alpha Therapy Shows Impressive Results Nearly three years of research have brought about remarkable results for the majority of 80 patients subjected to targeted alpha therapy of metastatic...
Prostate Cancer News FDA Grants Janssen Biotech’s Apalutamide Priority Review Designation to Treat Non-Metastatic CRPC The U.S. Food and Drug Administration (FDA) has granted priority review status to apalutamide — an investigational androgen receptor inhibitor — to tr...
